Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-26

Clinical Trial Update: Supplementation With Lactoferrin in Preterm Newborns [Phase 4]

View source ↗

Summary

Phase 4 trial update on lactoferrin supplementation in preterm newborns; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactoferrin (lactoferrin)

Snippet

Sponsor: University of Siena | Conditions: Prematurity, Low Birth Weight | Phase 4 | Status: COMPLETED